The Limited Times

Now you can see non-English news...

AstraZeneca vaccine accessible to over 65s: a new missed opportunity to simplify the French strategy


ANALYSIS - This measure risks perpetuating the false and dangerous idea that the AstraZeneca vaccine is less effective than the Pfizer / BioNTech and Moderna vaccines.

The end of the age limit at 65 for those eligible to receive the AstraZeneca vaccine is great news.

This will allow a greater number of vulnerable French people to be protected more quickly, which remains the priority more than ever in the fight against Covid.

Unfortunately, the health authorities have not gone far enough in simplification, and this measure risks perpetuating the false and dangerous idea that the vaccine invented in England by the University of Oxford and produced by AstraZeneca is less effective than the two messenger RNA vaccines from Pfizer / BioNTech and Moderna.


Because while the rule which limited the use of the British vaccine to under 65 years is abolished without age limit, Olivier Véran suggested last night that the use remained reserved for under 74 years.

It was in fact only a question of insisting on a forgotten population, which had access neither to AstraZeneca, nor to Pfizer or Moderna, except to suffer from

This article is for subscribers only.

You have 70% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time


Already subscribed?

Log in

Source: lefigaro

All tech articles on 2021-03-02

You may like

Tech/Game 2021-03-11T10:14:50.215Z
News/Politics 2021-03-05T10:40:52.134Z

Trends 24h

Tech/Game 2021-04-12T11:46:58.076Z


© Communities 2019 - Privacy